Market Tracker

10/31 10:16am ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.28
Data as of 9:54am ET
 +0.033 / +1.47%
Today’s Change
2.05
Today|||52-Week Range
5.30
-41.31%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close2.25
Today’s open2.30
Day’s range2.28 - 2.32
Volume103,143
Average volume (3 months)464,141
Market cap$215.4M
Dividend yield--
Data as of 9:54am ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BPTHBio-Path Holdings In...+0.04+1.52%
PSTIPluristem Therapeuti...-0.01-0.31%
AGENAgenus Inc-0.05-1.62%
QUREUniqure NV-0.44-4.02%
Data as of 10:14am ET, 10/31/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts